Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Novartis Ag (NVS)

2015-01-30@13:56:51 ET
Pharmaceutical Newsletter - January 27 to 30, 2015 (ABW)

2015-01-30@13:34:45 ET
Novartis AG (NVS) Trading Near $100.05 Resistance Level (FBM)

2015-01-30@08:48:01 ET
Research and Markets: CAR-T Therapies in Oncology Drug Pipeline Report 2015 (BIZ)

2015-01-30@07:33:40 ET
Global Cystic Fibrosis Market 2015-2019: Key Vendors are Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis and Vertex Pharmaceuticals (EUR)

2015-01-30@07:28:00 ET
Global Cystic Fibrosis Market 2015-2019: Key Vendors are Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis and Vertex Pharmaceuticals (PRN)

2015-01-30@05:42:56 ET
DELHI COURT RESTRICTS CIPLA FROM SELLING COPY OF NOVARTIS DRUG (ABW)

2015-01-30@03:24:04 ET
Novartis Q4 net income decreases (DTM)

2015-01-29@15:38:35 ET
Global Multiple Myeloma Drugs Market 2015-2019: Key Vendors are Celgene, Johnson & Johnson, Novartis, Onyx Pharmaceuticals, Sanofi and Takeda Pharmaceutical (EUR)

2015-01-29@15:35:00 ET
Global Multiple Myeloma Drugs Market 2015-2019: Key Vendors are Celgene, Johnson & Johnson, Novartis, Onyx Pharmaceuticals, Sanofi and Takeda Pharmaceutical (PRN)

2015-01-29@07:44:26 ET
Global Cystic Fibrosis Market 2015-2019: Key Vendors are Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis and Vertex Pharmaceuticals (PMZ)

2015-01-29@06:18:12 ET
Global Multiple Myeloma Drugs Market 2015-2019: Key Vendors are Celgene, Johnson & Johnson, Novartis, Onyx Pharmaceuticals, Sanofi and Takeda Pharmaceutical (PMZ)

2015-01-29@02:00:00 ET
Atlas Genetics Completes $20m Series C Fundraising (PRN)

2015-01-28@20:30:57 ET
India: NOVARTIS INDIA LTD. - 500672 - Outcome of Board Meeting (ABW)

2015-01-28@17:16:14 ET
US Patent Issued to Novartis on Jan. 27 for "Composition for repelling and deterring vermin" (Swiss, French Inventors) (ABW)

2015-01-28@17:00:56 ET
Novartis announces study in NEJM showing Jakavi(R) was superior to standard therapy in rare blood cancer polycythemia vera (HUG)

2015-01-28@08:13:19 ET
Form 144: Filing to Sell 10000 Shares of Novartis AG (NVS) (VKR)

2015-01-28@08:13:09 ET
Form 144: Filing to Sell 20000 Shares of Novartis AG (NVS) (VKR)

2015-01-28@03:47:12 ET
Intramuscular Drug Delivery Market & Pipeline Insight Report 2015 (MTO)

2015-01-27@20:00:00 ET
The Shuman Law Firm Investigates BioScrip, Inc. (BIZ)

2015-01-27@17:20:38 ET
After Yesterday's Rally of 2.53% Shares Could Potentially Pullback (PSM)